AFT Pharmaceuticals ROA 2024

AFT Pharmaceuticals Aktienanalyse

What does AFT Pharmaceuticals do?

AFT Pharmaceuticals Ltd is a New Zealand pharmaceutical company founded in 1997 by Hartley Atkinson. The company is headquartered in Auckland and operates in multiple countries. Business Model: AFT Pharmaceuticals' business model is focused on developing and marketing high-quality products. The company relies on product innovation and regularly introduces new medicines and supplements to the market. The company offers a wide range of products in various therapeutic areas such as pain management, respiratory diseases, gastrointestinal diseases, and skin conditions. AFT Pharmaceuticals has its own research and development facilities where they continuously work on new formulations and prioritize the needs of patients. The company also relies on partnerships to expand its presence globally and distribute its products in new markets. History: AFT Pharmaceuticals was founded in 1997 by Hartley Atkinson, who started by developing painkillers that were more effective and better tolerated than existing products. The company grew rapidly and expanded its offerings to meet additional medical needs. AFT Pharmaceuticals has since become one of the largest pharmaceutical companies in New Zealand and is expanding internationally. Divisions: An important area of AFT Pharmaceuticals is pain management. The company offers painkillers that are effective and safe, available in various forms. The portfolio includes both over-the-counter and prescription medicines that can be used to relieve pain, including migraine products. Another important area is respiratory diseases. AFT Pharmaceuticals manufactures medications that can be used for allergic rhinitis, asthma, and COPD. The medications are available in various forms such as tablets, syrup, inhalers, and nasal sprays. The company also offers products for gastrointestinal diseases that can be used for conditions such as heartburn, nausea, and vomiting. Dermatology is another important area. AFT Pharmaceuticals produces a variety of products that can be used to treat skin conditions such as eczema and psoriasis. Products: One of AFT Pharmaceuticals' most well-known product lines is Maxigesic, a painkiller that contains a combination of paracetamol and ibuprofen. The medication is available in many countries and is prescribed by doctors for a variety of pain types. Another popular product is Flutiform, an inhaler used for asthma and COPD. The inhaler is easy to use and highly effective. AFT Pharmaceuticals also offers a wide range of dietary supplements that contribute to overall health. These include products like Iron-C, a dietary supplement that contains iron and vitamin C to ensure good oxygen supply in the body. Overall, AFT Pharmaceuticals is a successful pharmaceutical company that offers a broad portfolio of medicines and dietary supplements available in many countries. The company relies on innovation and partnerships to expand its global presence. AFT Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding AFT Pharmaceuticals's Return on Assets (ROA)

AFT Pharmaceuticals's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing AFT Pharmaceuticals's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider AFT Pharmaceuticals's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in AFT Pharmaceuticals’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about AFT Pharmaceuticals stock

What is the Return on Assets (ROA) of AFT Pharmaceuticals this year?

The Return on Assets (ROA) of AFT Pharmaceuticals is 0 undefined this year.

What was the ROA of AFT Pharmaceuticals compared to the previous year?

The ROA of AFT Pharmaceuticals has increased by -100% compared to the previous year.

What consequences do high ROA have for investors of AFT Pharmaceuticals?

A high ROA is advantageous for investors of AFT Pharmaceuticals, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in AFT Pharmaceuticals?

A low ROA can be unfavorable for investors of AFT Pharmaceuticals as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of AFT Pharmaceuticals affect the company?

An increase in ROA of AFT Pharmaceuticals can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of AFT Pharmaceuticals impact the company?

A reduction in the ROA of AFT Pharmaceuticals can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of AFT Pharmaceuticals?

Some factors that can influence the ROA of AFT Pharmaceuticals include revenue, operating costs, asset structure, and industry average.

Why is the ROA of AFT Pharmaceuticals important for investors?

The ROA of AFT Pharmaceuticals is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can AFT Pharmaceuticals take to improve ROA?

To improve ROA, AFT Pharmaceuticals can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does AFT Pharmaceuticals pay?

Over the past 12 months, AFT Pharmaceuticals paid a dividend of 0.02 NZD . This corresponds to a dividend yield of about 0.48 %. For the coming 12 months, AFT Pharmaceuticals is expected to pay a dividend of 0.02 NZD.

What is the dividend yield of AFT Pharmaceuticals?

The current dividend yield of AFT Pharmaceuticals is 0.48 %.

When does AFT Pharmaceuticals pay dividends?

AFT Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of AFT Pharmaceuticals?

AFT Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of AFT Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0.02 NZD are expected. This corresponds to a dividend yield of 0.48 %.

In which sector is AFT Pharmaceuticals located?

AFT Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von AFT Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of AFT Pharmaceuticals from 7/4/2024 amounting to 0.016 NZD, you needed to have the stock in your portfolio before the ex-date on 6/19/2024.

When did AFT Pharmaceuticals pay the last dividend?

The last dividend was paid out on 7/4/2024.

What was the dividend of AFT Pharmaceuticals in the year 2023?

In the year 2023, AFT Pharmaceuticals distributed 0.011 NZD as dividends.

In which currency does AFT Pharmaceuticals pay out the dividend?

The dividends of AFT Pharmaceuticals are distributed in NZD.